Clinical characteristics and burden of illness among adolescent and adult patients with severe asthma by asthma control: the IDEAL study

被引:22
|
作者
Mullerova, Hana [1 ,6 ]
Cockle, Sarah M. [2 ]
Gunsoy, Necdet B. [3 ]
Nelsen, Linda M. [4 ]
Albers, Frank C. [5 ,7 ]
机构
[1] GSK, Real World Evidence, Stockley Pk, Uxbridge, Middx, England
[2] GSK House, Value Evidence & Outcomes, Brentford, Middx, England
[3] GSK, Value Evidence & Outcomes, Stockley Pk, Uxbridge, Middx, England
[4] GSK, Value Evidence & Outcomes, Collegeville, PA USA
[5] GSK, Resp Med Franchise, Res Triangle Pk, NC USA
[6] AstraZeneca, Resp Epidemiol, Cambridge, England
[7] Avill US Inc, Med Dept, Northbrook, IL 60062 USA
关键词
Control; management; morbidity and mortality; quality of life; QUALITY-OF-LIFE; EOSINOPHILIC ASTHMA; UNCONTROLLED ASTHMA; EXACERBATIONS; PHENOTYPES; OUTCOMES; COSTS; QUESTIONNAIRE; EPIDEMIOLOGY; MULTICENTER;
D O I
10.1080/02770903.2019.1708095
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Objectives: Severe asthma (SA) can be uncontrolled despite guideline-directed treatment. We described SA characteristics and identified factors associated with uncontrolled disease and frequent exacerbations. Methods: Post hoc analysis of the observational IDEAL study (201722/NCT02293265) included patients with SA aged >= 12 years receiving high-dose inhaled corticosteroids plus additional controller(s) for >= 12 months. Uncontrolled SA was defined by Asthma Control Questionnaire (ACQ)-5 scores >= 1.5 or >= 1 exacerbations (prior year), and further stratified by exacerbation frequency (no/infrequent [0-1] vs frequent [>= 2]; prior year); associated factors were determined using multivariate logistic regression. Results: Of 670 patients with SA, 540 (81%) were uncontrolled (ACQ-5 scores >= 1.5: 80%; >= 1 exacerbations [prior year]: 71%). Uncontrolled patients had lower lung function and worse health-related quality of life (HRQoL) than controlled patients; 197/540 (37%) experienced frequent exacerbations (prior year). Worse St George's Respiratory Questionnaire (SGRQ) total score, comorbid sinusitis, or eczema were significantly associated with uncontrolled SA; younger age, never smoker status, exacerbation requiring hospitalization (previous year), worse SGRQ symptom score, comorbid nasal polyps, COPD, or osteoporosis were significantly associated with uncontrolled SA with frequent exacerbations. Conclusions: In IDEAL, one-fifth of patients with SA were controlled, based on symptoms. Uncontrolled, exacerbating SA was associated with specific comorbidities, frequent exacerbations, a lower lung function, and compromised HRQoL, although inference from this analysis is limited by the selective cross-sectional nature of the cohort. Nonetheless, these data highlight the need for more effective precision treatments in this population.
引用
收藏
页码:459 / 470
页数:12
相关论文
共 50 条
  • [41] Statin use and asthma control in patients with severe asthma
    Zeki, Amir A.
    Oldham, Justin
    Wilson, Machelle
    Fortenko, Olga
    Goyal, Vishal
    Last, Michael
    Last, Andrew
    Patel, Ayan
    Last, Jerold A.
    Kenyon, Nicholas J.
    BMJ OPEN, 2013, 3 (08):
  • [42] Asthma control and disease burden in patients with asthma and allergic comorbidities
    Lee, Lulu K.
    Obi, Engels
    Paknis, Brandee
    Kavati, Abhishek
    Chipps, Bradley
    JOURNAL OF ASTHMA, 2018, 55 (02) : 208 - 219
  • [43] Biologics in Severe Asthma: An Ideal Choice for Achieving Control
    Kim, Sae-Hoon
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (03) : 214 - 216
  • [44] Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management
    Kostakou, Eirini
    Kaniaris, Evangelos
    Filiou, Effrosyni
    Vasileiadis, Ioannis
    Katsaounou, Paraskevi
    Tzortzaki, Eleni
    Koulouris, Nikolaos
    Koutsoukou, Antonia
    Rovina, Nikoletta
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (09)
  • [45] Economic burden of severe asthma in Turkey: a cost of illness study from payer perspective
    Bavbek, S.
    Malhan, S.
    Mungan, D.
    Misirligil, Z.
    Erdinc, M.
    Gemicioglu, B.
    Oguzulgen, I. Kivilcim
    Oksuz, E.
    Yildiz, F.
    Yorgancioglu, A.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 53 (03) : 128 - 137
  • [46] The economic burden of adult asthma in Cyprus; a prevalence-based cost of illness study
    Zannetos, Savvas
    Zachariadou, Theodora
    Zachariades, Andreas
    Georgiou, Andreas
    Talias, Michael A.
    BMC PUBLIC HEALTH, 2017, 17 : 1 - 9
  • [47] The economic burden of adult asthma in Cyprus; a prevalence-based cost of illness study
    Savvas Zannetos
    Theodora Zachariadou
    Andreas Zachariades
    Andreas Georgiou
    Michael A. Talias
    BMC Public Health, 17
  • [48] Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR)
    Dobbelaere, Stephanie
    Schleich, Florence
    Louis, Renaud
    Vandenplas, Olivier
    Michils, Alain
    Pilette, Charles
    Peche, Rudi
    Joos, Guy
    Brussele, Guy
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [49] The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
    Korn, Stephanie
    Milger, Katrin
    Skowasch, Dirk
    Timmermann, Hartmut
    Taube, Christian
    Idzko, Marco
    Voss, Hans Werner
    Holtdirk, Annette
    Hamelmann, Eckard
    Buhl, Roland
    RESPIRATORY MEDICINE, 2022, 195
  • [50] Clinical Characteristics and Management Strategies for Adult Obese Asthma Patients
    Farzan, Sherry
    Coyle, Tyrone
    Coscia, Gina
    Rebaza, Andre
    Santiago, Maria
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 673 - 689